INNOVATION & HIV SCIENCE
Understanding HIV & TB co-infection
HIV/TB co-infection, comorbidities, multiple infections; whichever term is used to describe it, treating people who are living with HIV (PLHIV) alongside another condition comes with its own challenges
A cure for HIV: the end goal
Through collaboration, we are advancing our efforts to discover a cure for the millions of people living with HIV.
HIV research – a panoramic view: using science to improve lives from all angles
Learn more about how we are driving innovation at Branford: the world’s first facility 100% dedicated to HIV research and science.
Advancing HIV science through collaboration
Explore how we work collaboratively to advance HIV research, and develop new treatment options for people living with HIV
Welcome to Branford: the world’s only HIV-dedicated research facility
“ViiV is one of the only companies dedicated to developing new medicines for people living with HIV”. – Dr Samit Joshi, Physician Product Lead in Clinical Development. Take a look around our HIV-focused discovery and research centre.
How we are collaborating to seek remission strategies in paediatric HIV research
The final part of this article outlines how ViiV Healthcare is collaborating with the Paediatric European Network for Treatment of AIDS (PENTA) Foundation to investigate strategies to achieve remission in children living with HIV.
Facing the Challenges of getting old with HIV
Advances in treatment have dramatically improved the life expectancy of people living with HIV (PLHIV), which is welcome progress. However, it comes with new medical challenges. By Dr Andrew Clark, Global Medical Lead, ViiV Healthcare
Improving Retention of Breastfeeding WLHIV on ART Challenge winner
ViiV Healthcare, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and Every Woman, Every Child (EWEC) have announced the winners of their Retention of Breastfeeding Mothers Challenge.